Research Article
Value of Liver Regeneration in Predicting Short-Term Prognosis for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure
Table 1
Clinical characteristics and outcomes of HBV-ACLF patients.
| | Training cohort () | Testing cohort () | |
| | Age (years) | | | 0.825 | | Gender (male, %) | 174 (84.47%) | 82 (80.39%) | 0.369 | | TBil (μmol/L) | 252.55 (86.50, 795.70) | 281.86 (86.61, 1004.50) | 0.528 | | Cre (μmol/L) | 73.70 (31.00, 505.00) | 74.30 (43.00, 371.00) | 0.793 | | Alb (g/L) | | | 0.428 | | Leukocyte count (×109/L) | 6.60 (1.80, 37.50) | 6.42 (2.16, 21.60) | 0.997 | | Neutrophil count (×109/L) | 4.31 (0.64, 33.38) | 4.54 (0.86, 16.83) | 0.778 | | ALT (IU/L) | 365.85 (21.80, 5124.20) | 302.00 (16.20, 6189.40) | 0.988 | | AST (IU/L) | 302.25 (40.50, 7025.20) | 318.35 (49.90, 3562.70) | 0.883 | | INR | 1.95 (1.50, 7.26) | 1.91 (1.50, 6.96) | 0.440 | | AFP (ng/mL) | 52.75 (1.04, 3858.00) | 35.87 (0.83, 1495.82) | 0.740 | | HBeAg positive (%) | 47 (22.82%) | 29 (28.43%) | 0.282 | | HBV DNA (log10 IU/mL) | 5.07 (2.01, 9.76) | 5.49 (2.30, 9.81) | 0.298 | | HE (%) | 109 (52.91%) | 55 (53.92%) | 0.867 | | Ascites (%) | 142 (68.93%) | 79 (77.45%) | 0.118 | | 28-day mortality (%) | 67 (32.52%) | 32 (31.37%) | 0.839 | | 90-day mortality (%) | 86 (41.75%) | 42 (41.18%) | 0.924 |
|
|
AFP: alpha-fetoprotein; Alb: albumin; ALT: alanine aminotransferase; AST: aspartate aminotransferase; Cre: creatine; HE: hepatic encephalopathy; INR: international normalized ratio; TBil: total bilirubin.
|
